Mumbai, India , is rapidly emerging as a key hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several firms have established substantial manufacturing units focusing on this critical antiviral medicine . Identifying the absolute top manufacturers can be challenging due to fluctuating market dynamics, but reputable names often incl